Clinical Trials Directory

Trials / Unknown

UnknownNCT05458414

Endoscopic Breast Conserving Surgery With Intra-operative Navigation System

Clinical Impacts of Margin Assessment and Aesthetic Outcomes of Endoscopic Breast Conserving Surgery With Intra-operative Navigation System

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
41 (estimated)
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
Sex
Female
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

A growing number of Chinese breast cancer patients are diagnosed at a young age. The quality of life of young breast cancer patients has been a critical issue. Breast-conserving surgery (BCS) not only removes the tumor but also maintains the appearance of breast. The Breast Tumor Center of Sun Yat-sen Memorial Hospital is one of the first departments in China to perform breast-conserving surgeries. Endoscopic breast surgery has emerged as a promising surgical approach. However, it is hard to delineate the tumor margins in endoscopic BCS, which restrains its development. In traditional BCS, surgeons determine the tumor border by palpation, which is impossible in endoscopic BCS. For the first time, we performed the intra-operative navigation system-assisted endoscopic breast-conserving surgery, in which the tumor border was accurately delineated using the navigation system.

Detailed description

In the study, patients who are female aged between 18 and 70 years, are pathologically diagnosed operable breast cancer, have proper the important organ functions and adjust to the criteria of endoscopic breast conserving surgery. Intraoperative and post-operatitive Margin Assessment will be the primary outcome measure, and aesthetic outcomes, reoperation rate, as well as patients' feedback will be the secondary outcome measure.

Conditions

Interventions

TypeNameDescription
DEVICEIntra-operative Navigation SystemIn the experimental group,a navigation technology was used to identify tumor margins during the surgery.

Timeline

Start date
2022-01-01
Primary completion
2024-12-01
Completion
2024-12-01
First posted
2022-07-14
Last updated
2022-07-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05458414. Inclusion in this directory is not an endorsement.